-
Sector Analysis
Primary CNS Lymphoma (PCNSL): Market View, Current and Future Competitive Landscape
This reports provides a data-driven overview of the current and future competitive landscape in Primary CNS Lymphoma Therapeutics._x000D_ _x000D_ • In 2024 and 2029, Urban China is anticipated to have the highest number of diagnosed prevalent cases of PCNSL, representing a large proportion of global cases. _x000D_ • Currently, PCNSL treatment relies mostly on off-label agents, and the Bruton's tyrosine kinase (BTK) inhibitors currently available to treat refractory/relapsed (r/r) PCNSL cases._x000D_ • The PCNSL pipeline holds 43 molecules, with no...
-
Sector Analysis
Emerging Market Outsourcing Report, Q1 2026
This expert outsourcing report is a comprehensive look at the pharmaceutical manufacturing landscape for emerging markets in Q1 2026, including analysis of news and trends affecting contract manufacturing organizations (CMOs) and the identification of recent contract service agreements, mergers, acquisitions, and financing among CMOs. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the pharmaceutical value chain that will provide insights into API (biologics and chemical) as well as dose manufacturing and...
-
Sector Analysis
Chemotherapy-Induced Peripheral Neuropathy (CIPN): Market View, Current and Future Competitive Landscape
CIPN Market Forecast, Clinical Trial Activity, and Competitive Intelligence GlobalData’s Chemotherapy-Induced Peripheral Neuropathy (CIPN) report delivers a data-driven overview of the current and future competitive landscape within the CIPN therapeutics market. The report highlights key trends across epidemiology, pipeline development, clinical trials, pricing and reimbursement, commercial activity, and future market catalysts. In addition, it provides insight into marketed therapies, emerging treatment approaches, and competitive positioning across the global market. China is anticipated to account for the highest number of diagnosed...
-
Sector Analysis
Bio/Pharmaceutical Outsourcing Report, February 2026
The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.
-
Thematic Analysis
Precision and Personalized Medicine - Advanced Therapeutics: Strategic Intelligence
Understand the Future of Precision and Personalized Medicine (PPM) Precision and personalized medicine is reshaping how diseases are diagnosed, treated, and managed. This report helps you understand where the market is heading and how advanced therapeutics are evolving. You will gain insight into how gene-modified cell therapies, gene therapy, and other advanced modalities are influencing treatment outcomes. Moreover, the report highlights how healthcare is shifting from reactive care to proactive, targeted intervention. As a result, you can better assess where...
-
Product Insights
Human Immunodeficiency Virus (HIV) Infections (AIDS): Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Human Immunodeficiency Virus (HIV) Infections (AIDS) - Global Clinical Trials Review, 2026" provides an overview of Human Immunodeficiency Virus (HIV) Infections (AIDS) Clinical trials scenario. This report provides top line data relating to the clinical trials on Human Immunodeficiency Virus (HIV) Infections (AIDS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase,...
-
Product Insights
Hepatitis B: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Hepatitis B - Global Clinical Trials Review, 2026" provides an overview of Hepatitis B Clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis B. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease): Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) - Global Clinical Trials Review, 2026" provides an overview of Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) Clinical trials scenario. This report provides top line data relating to the clinical trials on Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7...
-
Product Insights
Psoriatic Arthritis: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Psoriatic Arthritis - Global Clinical Trials Review, 2026" provides an overview of Psoriatic Arthritis Clinical trials scenario. This report provides top line data relating to the clinical trials on Psoriatic Arthritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Hyperlipidemia: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Hyperlipidemia - Global Clinical Trials Review, 2026" provides an overview of Hyperlipidemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperlipidemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.